midodrine has been researched along with phenylpropanolamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altenbach, RJ; Brioni, JD; Brune, ME; Buckner, SA; Cain, JC; Daza, AV; Gauvin, DM; Holladay, MW; Khilevich, A; Meyer, MD; Milicic, I; Nakane, M; O'Neill, AB; Sullivan, JP; Williams, M | 1 |
Alhasso, A; Glazener, CM; N'Dow, J; Pickard, R | 2 |
2 review(s) available for midodrine and phenylpropanolamine
Article | Year |
---|---|
Adrenergic drugs for urinary incontinence in adults.
Topics: Adrenergic Agonists; Adult; Clenbuterol; Female; Humans; Midodrine; Phenylpropanolamine; Randomized Controlled Trials as Topic; Urinary Incontinence; Urinary Incontinence, Stress | 2003 |
Adrenergic drugs for urinary incontinence in adults.
Topics: Adrenergic Agonists; Adult; Clenbuterol; Female; Humans; Midodrine; Phenylpropanolamine; Randomized Controlled Trials as Topic; Urinary Incontinence; Urinary Incontinence, Stress | 2005 |
1 other study(ies) available for midodrine and phenylpropanolamine
Article | Year |
---|---|
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta; Blood Pressure; Dogs; Female; Imidazoles; In Vitro Techniques; Ligands; Midodrine; Phenylpropanolamine; Rabbits; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Spleen; Structure-Activity Relationship; Sulfonamides; Urethra | 2002 |